Portal vein embolization: Rationale, technique and future prospects

British Journal of Surgery

Volumn 88, Issue 2, 2001, Pages 165-175

  Abdalla, E K ^a   Hicks, M E ^a   Vauthey, J N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYANOACRYLATE; ENBUCRILATE; FIBRIN GLUE; GELFOAM; GENTAMICIN; IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE; THROMBIN;

ARTIFICIAL EMBOLISM; DIGESTIVE SYSTEM CANCER; HEPATOBILIARY DISEASE; HEPATOBILIARY SYSTEM CANCER; HUMAN; LIVER CIRRHOSIS; LIVER REGENERATION; LIVER SIZE; MORBIDITY; MORTALITY; PARTIAL HEPATECTOMY; PORTAL VEIN; PRIORITY JOURNAL; REVIEW; TECHNIQUE; TREATMENT INDICATION;

BLOOD LOSS, SURGICAL; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; HUMANS; HYPERTROPHY; LIVER DISEASES; LIVER REGENERATION; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035130470     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2001.01658.x     Document Type: Review

References (88)

1. Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis
2. Comparison of outcome between extended and nonextended liver resections for neoplasms
3. One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique
4. Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts
5. Major liver resection for hilar cholangiocarcinoma
6. Morbidity and mortality after surgical resection of liver rumors. Analysis of 229 cases
7. Morbidity and mortality after hepatic resection of metastases from colorectal cancer
8. Is radical hepatic surgery safe?
9. Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients
10. Risk factors for prolonged length of stay after major elective surgery
11. Preoperative portal vein embolization for hepatocellular carcinoma
12. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report
13. Relation of the portal blood to liver maintenance. A demonstration of liver atrophy conditional on compensation
14. Atrophy of the liver after occlusion of the bile ducts or portal vein and compensatory hypertrophy of the unoccluded portion and its clinical importance
15. Ligation of a branch of the portal vein for carcinoma of the liver
16. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma
17. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization
18. Interaction between portal venous and hepatic arterial blood flow; an experimental study in the dog
19. Liver regeneration
20. Hepatocyte growth factor
21. Liver regeneration in health and disease
22. 3) assay of mitochondria from liver specimens: An aid in determining metabolic tolerance of liver remnant for hepatic resection
23. Quantitative liver functions after 70% hepatectomy
24. Stimulated rat liver mitochondrial biogenesis after partial hepatectomy
25. Enhancement of rat liver mitochondrial function by portal branch ligation secures subsequent extended hepatectomy
26. Effect of ligation of portal vein in liver mitochondrial metabolism
27. The effect of splanchnic viscera removal upon canine liver regeneration
28. Induction of DNA synthesis in cultured rat hepatocytes through stimulation of alpha 1 adrenoreceptor by norepinephrine
29. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization
30. Exogenous hepatocyte growth factor markedly stimulates liver regeneration following portal branch ligation in dogs
31. Embolization of portal branches induces hepatocyte replication in swine: A potential step in hepatic gene therapy
32. The extracellular matrix in hepatic regeneration
33. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium
34. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor
35. Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon
36. Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization
37. Tritiated thymidine autoradiography in the regenerating liver of the dog
38. Thymidine kinase: An inexpensive index of liver regeneration in a large animal model
39. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function
40. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: A clinical study
41. Portal vein embolization: Utility for inducing left hepatic lobe hypertrophy before surgery
42. Right portal vein embolization in preparation for major hepatic resection
43. A minimally invasive approach to the treatment of stenosis of the portal vein after hepatic transplantation
44. Percutaneous transhepatic portal embolization using newly devised catheters: Preliminary report
45. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma
46. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices
47. Recovery from hepatic necrosis following acute portal vein embolism with special reference to reconstruction of occluded vessels
48. New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma - An old problem revisited
49. Radical operation after portal embolization for tumor of hilar bile duct
50. Preoperative portal vein embolization for extension of hepatectomy indications
51. Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: A preliminary report
52. Preoperative portal vein embolization: An audit of 84 patients
53. Résultats carcinologiques à long terme des hépatectomies réalisées après embolisation portale sélective
54. Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations
55. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization
56. Experimental studies of intrahepatic portal vein embolization and embolic materials
57. Portal vein embolization with steel coils and absolute ethanol: A comparative experimental study with canine liver
58. Selective portal vein embolization with absolute ethanol induces hepatic hypertrophy and makes more extensive hepatectomy possible
59. Right trisegment portal vein embolization for biliary tract carcinoma: Technique and clinical utility
60. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma
61. Hepatic regeneration after major hepatectomy
62. Regeneration of human liver after hepatic lobectomy studied by repeated liver scanning and repeated needle biopsy
63. The ultrastructure, kinetics and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes
64. Measurement of liver and spleen volume by computed tomography. Assessment of reproducibility and changes found following a selective distal splenorenal shunt
65. Hepatic metastases from colorectal cancer: Influence of hepatic volumetric analysis on surgical decision-making
66. Measurement of liver volume by ultrasound and computed tomography
67. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography
68. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors
69. The significance of measuring liver, using computed tomographic images before and after hepatectomy
70. Calculation of child and adult standard liver volume for liver transplantation
71. Graft size assessment by preoperative computed tomography in living related partial liver transplantation
72. Preoperative measurement of segmental liver volume of donors for living related liver transplantation
73. Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract
74. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function
75. Changes in hepatic lobar function after fight portal vein embolization. An appraisal by biliary indocyanine green excretion
76. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography
77. 99mTc-GSA) liver scintigraphy
78. Resection of hepatic metastases from colorectal cancer
79. Resection and embolization in the management of secondary hepatic tumors
80. Hepatic resection for secondary neoplasms
81. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer: 1. Treatment by hepatic resection
82. Clinical perspective on human colorectal cancer metastasis
83. Carcinoma of the bifurcation of the hepatic ducts
84. Surgical treatment of hilar carcinoma of the bile duct
85. Carcinoma of the hepatic hilus. Surgical management and the case for resection
86. Prognostic factors in bile duct carcinoma: Analysis of 96 cases
87. Carcinoma of the extrahepatic bile ducts: Results of an aggressive surgical approach
88. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment